Medscape www.medscape.com

Figures for:
T-Cell Therapy of Leukemia

[Cancer Control 9(2):152-166, 2002. © 2002 H. Lee Moffitt Cancer Center and Research Institute, Inc]


Figure 1. Tissue-specific recognition of mHAgs may permit separation of GVL and GVHD. Donor T cells specific for mHAgs that are broadly expressed by both hematopoietic and nonhematopoietic cells have been implicated in GVHD. Donor T cells specific for mHAgs that are expressed preferentially or selectively in recipient hematopoietic cells including leukemia progenitors may be targets for a GVL response without GVHD.

Figure 2. Evaluating T-cell recognition of leukemia progenitors using NOD/SCID mice. The leukemia cell population consists of a hierarchy of cells with distinct capacity for self-renewal. A putative stem cell is required for engraftment in irradiated NOD/SCID mice. The ability to purge the leukemia population of cells capable of establishing leukemic hematopoiesis by co-culture with antigen-specific T cells can be used to assess recognition of the leukemic stem cell.